Literature DB >> 19665604

Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.

V Dirix1, V Verscheure, T Goetghebuer, M Hainaut, A S Debrie, C Locht, F Mascart.   

Abstract

Two different types of pertussis vaccines are currently available to protect children against whooping cough, the first-generation whole-cell (Pw) vaccines and the more recent acellular (Pa) vaccines. Both types provide good protection, yet induce different types of immune responses in 6-month-old infants, with a strong Th1 response induced by Pw vaccines compared to a mixed Th1/Th2 response and a delay in non-specific IFN-gamma secretions after the administration of Pa vaccines. We show here that at 13 months of age, most Pw- or Pa-vaccinated children display Bordetella pertussis-specific T-cell responses, in addition to significant antibody levels, although a higher Th2/Th1 cytokine ratio remained in Pa recipients compared to Pw recipients. In contrast, the proportion of children with tetanus toxin-specific T-cell responses was lower in Pa than in Pw vaccine recipients, although most children had protective anti-tetanus toxin IgG levels. In addition, the global Th2 bias observed in 6-month-old infants vaccinated with a Pa vaccine was normalized at 13 months.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665604     DOI: 10.1016/j.vaccine.2009.07.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  Composition of pertussis vaccine given to infants determines long-term T cell polarization.

Authors:  Stanley A Plotkin
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

Review 3.  What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines.

Authors:  Nicolas Burdin; Lori Kestenbaum Handy; Stanley A Plotkin
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-12-01       Impact factor: 10.005

4.  A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.

Authors:  Ciaran M Skerry; Bernard P Mahon
Journal:  Clin Vaccine Immunol       Date:  2010-12-08

5.  Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines.

Authors:  Françoise Vermeulen; Virginie Verscheure; Eliane Damis; Danièle Vermeylen; Gaëlle Leloux; Violette Dirix; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

Review 6.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

7.  Both CD4⁺ and CD8⁺ lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults.

Authors:  Violette Dirix; Virginie Verscheure; Françoise Vermeulen; Iris De Schutter; Tessa Goetghebuer; Camille Locht; Françoise Mascart
Journal:  Clin Dev Immunol       Date:  2012-04-08

8.  The Effect of Maternal Pertussis Immunization on Infant Vaccine Responses to a Booster Pertussis-Containing Vaccine in Vietnam.

Authors:  Kirsten Maertens; Thi Thu Ha Hoang; Trung Dac Nguyen; Raïssa Nadège Caboré; Thi Hong Duong; Kris Huygen; Niel Hens; Pierre Van Damme; Duc Anh Dang; Elke Leuridan
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

9.  Acellular pertussis vaccines and pertussis resurgence: revise or replace?

Authors:  Clara Maria Ausiello; Antonio Cassone
Journal:  MBio       Date:  2014-06-10       Impact factor: 7.867

10.  Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles.

Authors:  Saskia van der Lee; Lotte H Hendrikx; Elisabeth A M Sanders; Guy A M Berbers; Anne-Marie Buisman
Journal:  Front Immunol       Date:  2018-01-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.